Ginkgo Bioworks Holdings, Inc. DNA
We take great care to ensure that the data presented and summarized in this overview for Ginkgo Bioworks Holdings, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding DNA
View all-
Black Rock Inc. New York, NY42MShares$397 Million0.0% of portfolio
-
Titleist Asset Management, Ltd. San Antonio, TX2.31MShares$21.9 Million0.92% of portfolio
-
Putnam Investments LLC Boston, MA1.5MShares$14.2 Million0.0% of portfolio
-
Credit Suisse Ag Zurich, V81.15MShares$10.8 Million0.0% of portfolio
-
Benjamin F. Edwards & Company, Inc. St. Louis, MO235KShares$2.22 Million0.0% of portfolio
-
Aj Wealth Strategies, LLC197KShares$1.87 Million0.02% of portfolio
-
Pathstone Family Office, LLC Englewood, NJ162KShares$1.53 Million0.0% of portfolio
-
Pictet Asset Management Sa Geneva 73, V8102KShares$967,9090.0% of portfolio
-
American Portfolios Advisors Holbrook, NY70.3KShares$665,1040.01% of portfolio
-
Rothschild Investment Corp61.9KShares$585,5740.01% of portfolio
Latest Institutional Activity in DNA
Top Purchases
Top Sells
About DNA
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Insider Transactions at DNA
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 11
2024
|
Harry Sloan Director |
BUY
Other acquisition or disposition
|
Direct |
235,780
+47.5%
|
-
|
|
Dec 04
2024
|
Steven P. Coen Officer |
SELL
Open market or private sale
|
Direct |
330
-4.58%
|
$2,970
$9.64 P/Share
|
|
Dec 04
2024
|
Mark E. Dmytruk Officer |
SELL
Open market or private sale
|
Direct |
741
-2.24%
|
$6,669
$9.64 P/Share
|
|
Dec 03
2024
|
Steven P. Coen Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
743
+4.91%
|
-
|
|
Dec 03
2024
|
Mark E. Dmytruk Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,517
+1.15%
|
-
|
|
Nov 22
2024
|
Harry Sloan Director |
BUY
Other acquisition or disposition
|
Direct |
4,222
+0.51%
|
-
|
|
Nov 04
2024
|
Steven P. Coen Officer |
SELL
Open market or private sale
|
Direct |
333
-4.91%
|
$2,331
$7.58 P/Share
|
|
Nov 04
2024
|
Mark E. Dmytruk Officer |
SELL
Open market or private sale
|
Direct |
1,322
-4.01%
|
$9,254
$7.58 P/Share
|
|
Nov 01
2024
|
Steven P. Coen Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
743
+5.19%
|
-
|
|
Nov 01
2024
|
Mark E. Dmytruk Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,695
+2.02%
|
-
|
|
Oct 04
2024
|
Mark E. Dmytruk Officer |
SELL
Open market or private sale
|
Direct |
1,217
-3.87%
|
$9,736
$8.35 P/Share
|
|
Oct 04
2024
|
Steven P. Coen Officer |
SELL
Open market or private sale
|
Direct |
306
-4.82%
|
$2,448
$8.35 P/Share
|
|
Oct 03
2024
|
Mark E. Dmytruk Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,705
+2.12%
|
-
|
|
Oct 03
2024
|
Steven P. Coen Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
743
+5.53%
|
-
|
|
Sep 12
2024
|
Mark E. Dmytruk Officer |
SELL
Open market or private sale
|
Direct |
1,148
-3.84%
|
$6,888
$6.17 P/Share
|
|
Sep 12
2024
|
Steven P. Coen Officer |
SELL
Open market or private sale
|
Direct |
316
-5.33%
|
$1,896
$6.17 P/Share
|
|
Sep 11
2024
|
Mark E. Dmytruk Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,693
+2.22%
|
-
|
|
Sep 11
2024
|
Steven P. Coen Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
743
+5.9%
|
-
|
|
Aug 02
2024
|
Steven P. Coen Officer |
SELL
Open market or private sale
|
Direct |
17,486
-7.78%
|
$0
$0.29 P/Share
|
|
Aug 02
2024
|
Mark E. Dmytruk Officer |
SELL
Open market or private sale
|
Direct |
63,567
-5.52%
|
$0
$0.29 P/Share
|
Last 12 Months Summary
| Other acquisition or disposition | 240K shares |
|---|---|
| Exercise of conversion of derivative security | 1.93M shares |
| Open market or private purchase | 923K shares |
| Open market or private sale | 2.76M shares |
|---|